TCGA team remodeled ccRCC through a stratification remodeling study from the levels of genomic alterations, DNA methylation profiles, RNA, and proteomic signature and finally found that the PI3K/AKT pathway was recurrently mutated, suggesting that this pathway is a potential therapeutic target [41]. Here, PIK3CA is linked to nonpapillary renal cell carcinoma.